English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Regeneron Pharmaceuticals
+
Regulatory
Press release submission
| Jan 2, 2021
REGENERON: Announces Encouraging Initial Data from COVID-19 Antibody Cocktail Trial in Hospitalized Patients on Low-flow Oxygen
+
Regulatory
Press release submission
| Jul 5, 2020
Regeneron and Sanofi Provide Update on Kevzara® (sarilumab) Phase 3 U.S. Trial in COVID-19 Patients
+
Technology/Innovation
Carol Ostrow
| Sep 23, 2017
Study shows Dupixent reduces symptoms of atopic dermatitis
+
Technology/Innovation
Ruth de Jauregui
| May 7, 2017
Survey finds majority of rheumatoid arthritis patients living in pain
+
Regulatory
Ruth de Jauregui
| Apr 2, 2017
FDA approves Dupixent for atopic dermatitis
Trending
+
Pharmaceuticals
Patient Daily
| Aug 4, 2026
Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+
Pharmaceuticals
Patient Daily
| Aug 6, 2026
FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+
Regulatory
M. R. Armstrong
| Aug 4, 2026
Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+
Pharmaceuticals
Patient Daily
| Aug 5, 2026
Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes
